MiR-342 Attenuates Lipopolysaccharide-Induced Acute Lung Injury via Inhibiting MAPK1 Expression
Clinical and Experimental Pharmacology and Physiology - United Kingdom
doi 10.1111/1440-1681.13315
Full Text
Open PDFAbstract
Available in full text
Date
April 5, 2020
Authors
Publisher
Wiley